Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00640939 · ClinicalTrials.gov registry record · Phase 2
Diclofenac Patch for Treatment of Mild to Moderate Tendonitis or Bursitis
A Phase 2 study, sponsored by Cerimon Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 308
- Enrollment target
NCT00640939 is a Phase 2 study that has completed, run by Cerimon Pharmaceuticals. The registered enrollment target is 308 participants.
The verdict
NCT00640939, a Phase 2 study, has completed, sponsored by Cerimon Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 308 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium patch to the skin near or over the painful area. In this study, the location being studied will be one of the following: the affected shoulder, elbow, or wrist. The secondary purpose of this study is to assess the safety and tolerability of the diclofenac patch on the subject's skin, in the location being studied.
Interventions
- DRUG Matching Placebo
- DRUG diclofenac sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 308 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00640939
The ClinicalTrials.gov registry entry for NCT00640939 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 308 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cerimon Pharmaceuticals, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Matching Placebo is the first listed.
NCT00640939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00640939 about?
NCT00640939 is a clinical study titled "Diclofenac Patch for Treatment of Mild to Moderate Tendonitis or Bursitis". The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium patch to the skin near or over the painful area. In this study, the location being studied will be one of the following: the affected shoulder, elbow, or wrist. The secondary purpose of...
What is the current status of trial NCT00640939?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 308 participants. The study started on 2007-12. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00640939?
The interventions under investigation include: Matching Placebo (DRUG), diclofenac sodium (DRUG).
Who is sponsoring clinical trial NCT00640939?
This trial is sponsored by Cerimon Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.